BU-NOT-SET

CONTACT US
Nitrosamines analysis
  • Analytical chemistry
Nitrosamines analysis
Fact sheet
Enabling oral solid dosage form delivery of biologics
  • Biologics
  • Drug substance
oral biologics
Insight
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Increasing carbon emission transparency through SBTi contributions
  • Sustainability
SBTi
Insight
Single-use technologies are enabling increasing demand for biologics
  • Biologics
People
Insight
Fact sheet
  • Drug product
Fixed dose combinations - for improved patient compliance
Insight
  • Industry trends
The current state of contract manufacturing
Insight
  • Industry trends
The potential impact of Brexit on patient safety
Insight
  • Manufacturing
EU FMD: After the deadline
Insight
  • Manufacturing
The importance of supply chain security
Insight
  • Drug substance
ADC development: setbacks and key developments
Insight
  • Drug substance
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Insight
  • Industry trends
CDMO trends: Drug development and industry consolidation
Insight
  • Industry trends
Consolidation in the CDMO Market